Michael Levin

Wednesday Options Update: UTX, GE, USB, WMT, NTRS, BK & CVTX

You mean the buyer of the April $10 - $15 call spread at $1.95 stands to make $3.05 not the 2.05 that you stated. I myself make mistakes too, so not being immune to stating the wrong thing at times on here. I am wildly Bullish on CVTX, having recc. it below $9 and recc. The April $10 call at $1.50 a month ago and calling for it to hit $6.00 each by Aprils option expiration...

Michael Levin

Thursday Options Update: LVS, CSCO, NWS, CVTX, BAC & WMT

Andrew, you might want to check the facts when you say that Renexa is CVTX's "ONLY" drug... Maybe Tecadenoson (Approved) being sold for upfront royalties of over $150 Million might indicate more than 1 iron in the fire...

Take a look at Yahoo under Profile to see everything they have going on.

What's Ailing the Pharmaceutical Sector?

Yes, that is true, but they will still make $ and develop newer drugs and raise the bar for pricing anyway.

There are always "reasons" why some stocks go on sale and then there are "reasons" why they eventually go up again.

Merck went from $26 in November 2006 to $61 in December of 2008, a span of 25 months and in 6 months it has given back almost exactly 75% of the gains.

I would think that some consolidation or "relief rally" of sorts is in order here, now at this level of $35

Discovery Labs: Panic at the DSCO

You are right about the date, I goofed, and yes, it is possible that nothing will happen in time for these June Calls... But if it does, the potential returns are quite large.

Buying the stock is the smartest thing over the next few months and buying the calls is just for fun, maybe a LOT of fun...